Navigation Links
Extended HPV Vaccine Schedule Seems Effective
Date:4/12/2011

TUESDAY, April 12 (HealthDay News) -- Giving doses of human papillomavirus (HPV) vaccine over a longer-than-normal period of time may prove an effective way to make the vaccine available to more females in poorer nations, a new study suggests.

HPV is a transmittable virus and the primary cause of cervical cancer, which kills about 275,000 women worldwide each year. About 88 percent of those deaths occur in developing nations, according to background information in the study.

"Combined with continued strengthening of simple evidence-based screening and treatment approaches, effective HPV vaccine programs could reduce cervical cancer rates in developing countries to the low levels currently observed in many developed countries," said Dr. Kathleen M. Neuzil, of PATH, a nonprofit organization located in Seattle whose stated mission is to improve global health, in a PATH news release. "One challenge to broadly implementing HPV vaccination programs in developing countries will be delivering the currently recommended three doses of vaccine to adolescents within six months (dosing schedules at 0, 2, and 6 months or at 0, 1, and 6 months)."

Even in countries where these dosing schedules are feasible, alternative dosing schedules may offer advantages such as lower cost (the vaccine could be given along with other health services) and increased coverage due to greater convenience for girls and their families or for vaccination teams, the study authors noted.

In this study, the researchers looked at four different dosing schedules used to give HPV vaccine to 903 adolescents girls at 21 schools in Vietnam. The doses were given according to a standard schedule of 0, 2 and 6 months or one of three alternative schedules (0, 3 and 9 months; 0, 6 and 12 months; or 0, 12 and 24 months).

The girls in the alternative dosing schedule groups developed antibody concentration levels similar to the girls in the standard dosing group, and no serious adverse events were reported.

The study findings are published in the April 13 issue of the Journal of the American Medical Association, a theme issue on infectious diseases and immunology.

"The similarity of the immunogenicity and reactogenicity profiles of the HPV vaccine reported from this predominantly ethnic minority population in a low-resource area of Vietnam and other populations throughout the world is reassuring and supports more widespread introduction of the vaccine. The World Health Organization acknowledges that programmatic constraints must be considered in the decision to commence national HPV immunization programs. The option of delivering HPV vaccine on flexible schedules will allow countries to minimize costs and maximize feasibility according to local vaccination practices," Neuzil's team concluded.

More information

The U.S. National Cancer Institute has more about HPV vaccination.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, April 12, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Lung cancer patients receiving palliative care had improved quality of life, extended survival
2. Extended use of anti-clotting drug helps some bedridden patients
3. Extended Sizes and Accessories for Medical Walking Boots are Now Available from Orthotics And Beyond
4. Vitamins for Life Inventory Extended to Wellness Products, Higher Nature Supplements
5. Treadmill Doctor 360 Degree Guarantee Extended Service Plans
6. BETE Fog Nozzle Announces HydroWhirl™ Orbitor – Clean-In-Place Rotating Tank Cleaning Machine with High Impact Cleaning for Extended Operating Life
7. Extended hepatitis C treatment after liver transplant may benefit patients
8. Alterian Announces Extended Partnership with youDb in Brazil
9. HITSP Contract With U.S. HHS Extended Through April 2010
10. Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine
11. Brain Tumor Vaccine Shows Promise in Early Trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extended HPV Vaccine Schedule Seems Effective
(Date:5/24/2016)... ... May 24, 2016 , ... ... or injury that focuses on repairing the musculoskeletal and neuromuscular systems of the ... on functional restoration, NYDNRehab began providing treatments for physical therapy in New York, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, ... the official relaunch of its community and education hub for women considering fertility ... is to create a safe and welcoming place for women to find cycle ...
(Date:5/24/2016)... Washington, DC (PRWEB) , ... May 24, 2016 ... ... to consumers for 2016 increased by 9.3 million people, or 10% over last ... The number of people covered under group policies was comparatively stable, with a ...
(Date:5/24/2016)... ... 2016 , ... WaterAid launched the #perioddrama campaign to mark Menstrual Hygiene Day on ... around the world who do not have access to a toilet, even when they’re on ... dread of #perioddrama. The (sometimes hilarious) results help shine a light on the awkwardness that ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... today announced a licensing relationship that will deliver a new series of Q&A ... will put the medical knowledge and expertise of Harvard Medical School faculty into ...
Breaking Medicine News(10 mins):
(Date:5/20/2016)... , May 20, 2016 ... veteran investors believe that the industry is not far ... and today ActiveWallSt.com featured the following four equities: Anacor ... (NASDAQ: ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free ...
(Date:5/19/2016)... 2016  According to the World Health Organization ... basic diagnostic imaging. Whereas mammography or X-ray are ... States , many places around the world ... the WHO reports that those approximately 4 billion ... death, simply due to the unavailability of radiology. ...
(Date:5/19/2016)... Oregon , May 19, 2016 ... titled, World Medical/Diagnostic Imaging Market -Opportunities and Forecasts, 2015 ... reach $45.0 billion by 2022, registering a CAGR of ... expected to continue to be the highest revenue-generating segment ... accounted for around one-third of the market share ...
Breaking Medicine Technology: